510(k) Report

510(k) · Cleared

Cleared

MBCP+

K093122510(k) TraditionalCleared Mar 15, 2010164-day reviewClass II21 CFR 872.3930

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Biomatlante · LYC Bone Grafting Material, Synthetic

Cleared on Mar 15, 2010 as substantially equivalent to K042706 (Isotis Orthobiologics, Inc., 2004) and 2 other predicates after a 164-day review. Its family tree reaches back 5 generations to 1999.

Decided
Mar 15, 2010
Review
164 days
Class
Class II
Product code
LYC
Recalls
None
Predicates
3

Its longest line of descent runs back 5 generations to K990131 (1999). 26 ancestors in all, the oldest P800035 (1981). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2005: 1 other ancestor2004: 3 other ancestors1999: 1 other ancestor1998: 2 other ancestors1986: 1 other ancestor1981: 1 other ancestor2000: 3 other ancestors1996: 1 other ancestor1995: 4 other ancestors1993: 1 other ancestor1992: 1 other ancestor1987: 1 other ancestor1985: 1 other ancestorK990131 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute · Interpore Cross Intl. · 1999K020986 · Mastergraft Resorbable Ceramic · Medtronic Sofamor Danek, Inc. · 2002K032268 · MBCP · Biomatlante · 2003K043005 · Modification to MBCP · Biomatlante · 2005K051885 · MBCP · Biomatlante · 20051980198519901995200020052010
Other ancestors, by generation 1 generation back: 2 other ancestors2 generations back: 7 other ancestors3 generations back: 10 other ancestors4 generations back: 2 other ancestors K051885 · MBCP · Biomatlante · 2005K043005 · Modification to MBCP · Biomatlante · 2005K032268 · MBCP · Biomatlante · 2003K020986 · Mastergraft Resorbable Ceramic · Medtronic Sofamor Danek, Inc. · 2002K990131 · Pro Osteon Implant 500R Resorbable Bone Graft Substitute · Interpore Cross Intl. · 1999−50
  1. Root · 5 generations backK990131 Pro Osteon Implant 500R Resorbable Bone Graft SubstituteInterpore Cross Intl. · 1999
  2. 4 generations backK020986 Mastergraft Resorbable CeramicMedtronic Sofamor Danek, Inc. · 2002
  3. 3 generations backK032268 MBCPBiomatlante · 2003
  4. 2 generations backK043005 Modification to MBCPBiomatlante · 2005
  5. 1 generation backK051885 MBCPBiomatlante · 2005
  6. This deviceK093122 MBCP+Biomatlante · 2010
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K990131Pro Osteon Implant 500R Resorbable Bone Graft SubstituteInterpore Cross Intl.1999—
−4K020986Mastergraft Resorbable CeramicMedtronic Sofamor Danek, Inc.2002—
−3K032268MBCPBiomatlante2003—
−2K043005Modification to MBCPBiomatlante2005—
−1K051885MBCPBiomatlante2005—
0 (this device)K093122MBCP+Biomatlante2010—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198110
198510
198610
198710
199210
199310
199540
199610
199820
199910
200030
200430
200510
FIG. 1 — Lineage of K093122, 1999–2010Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LYC? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LYC device

  1. #1 K253317 Cytrans™ Elashieldscore 14.3 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (3)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K042706Ossatura Dental
Summary page 2
…uct Applicant Class 51 0(k) number OsSaturam Dental Isotis Orthobiologics, Inc. 11 K042706 CerasorbtM Dental Curasan AG II K051443 MBCPM' Bi…
Isotis Orthobiologics, Inc.2004—
*K051443Cerasorb Dental, Cerasorb M Dental and Cerasorb Perio
Summary page 2
…am Dental Isotis Orthobiologics, Inc. 11 K042706 CerasorbtM Dental Curasan AG II K051443 MBCPM' Biomatlante II K051885 K. Device Description MBCP+…
Curasan Ag, Frankfurt Facility2005—
*K051885MBCP
Summary page 2
…btM Dental Curasan AG II K051443 MBCPM' Biomatlante II K051885 K. Device Description MBCP+ Th is a bone graft material used in dental applications. The MBCP+Th product consists of a bi…
Biomatlante2005—

Also cleared against K042706: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 3 companies; a new generation was cleared every 1.4 years on median.
  • None of the 26 ancestors has a recall.
  • 3 other devices also cite its predicate K042706.

How does its category compare?

All LYC devices

LYC Bone Grafting Material, Synthetic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · LYC

3in 2025

2007: 132008: 82009: 142010: 132011: 92012: 52013: 22014: 12016: 22020: 32022: 22025: 32026 (partial year): 3
2007high 14 (2009) · low 0 (2015)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LYC

267in 2025

2007: 80 days median2008: 73 days median2009: 100 days median2010: 164 days median2011: 224 days median2012: 120 days median2020: 156 days median2025: 267 days median2026 (partial year): 266 days median
2007high 267 (2025) · low 73 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LYC

1in 2018

2009: 12010: 22012: 22016: 22018: 1
2007high 2 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LYC

2in 2025

2007: 232008: 252009: 252010: 282011: 212012: 102013: 122014: 92015: 142016: 1402017: 192018: 142019: 152020: 52021: 122022: 62023: 92024: 62025: 2
2007high 140 (2016) · low 2 (2025)2025

MAUDE reports naming product code LYC, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071380023
2008873025
200914100125
201013164228
20119224021
20125120210
20132—012
20141—09
20150—014
20162—2140
20170—019
20180—114
20190—015
2020315605
20210—012
20222—06
20230—09
20240—06
2025326702
202632660—

What is it indicated for?

MBCP+TM is intended for use as a bone grafting material to fill, augment or reconstruct periodontal or bony defects of the oral and maxillofacial region.

These defects may be surgically created osseous defects or osseous defects created from traumatic injury to the bone.

MBCP+TM can be used with autogenous bone grafting materials.

Typical uses include:

* Periodontal/infrabony defects

* Ridge augmentation

* Extraction sites (implant preparation/placement)

* Sinus lifts

* Cystic cavities

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K093122: MBCP+.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K093122

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026